GoldenGolden
Advanced Search
Empatica

Empatica

Empatica designs and develops wearable health devices for health monitoring, treatment, and research.

Empatica is a Cambridge, MA-based company that designs, produces, and develops AI-enabled wearables, software, and digital markers. These wearables are used in health monitoring, treatment, and research. Obstacles to utilizing wearable technologies include privacy compliance and HIPAA data standards.

Embrace2 is an FDA-cleared medical device that is worn on the wrist and can detect patterns that may be associated with a generalized tonic-clonic seizure and immediately alert caregivers and a physician with information about the patient. FDA clearance allows it to be used by children ages six and up; it is first epilepsy monitoring device to receive clearance for pediatric use.The device works through four sensors: electrodermal activity, temperature, accelerometer, and gyroscope. The device is available by prescription only.

Marlborough, Massachusetts-based pharma company Sunovion used the Empatica Embrace2 in a 2016 phase 4 clinical study of Aptiom, a drug meant to reduce seizures in people with epilepsy.

Timeline

April 2017
Empatica raises a $5,000,000 series A round from Endeavor Catalyst, Innogest Capital and Invitalia Ventures.
March 2015
Empatica raises a $780,000 crowdfunding.
July 2014
Empatica raises a $2,000,000 seed round.
2011
Empatica was founded by Rosalind Picard, Matteo Lai, Maurizio Garbarino, Rosalind Picard and Simone Tognetti.

Funding rounds

People

Further reading

Documentaries, videos and podcasts

Companies

News

Title
Author
Date
Publisher
Description
Empatica
April 15, 2021
www.prnewswire.com:443
/PRNewswire/ -- EmbracePlus by Empatica has received the European CE mark as a Class lla medical device, for its ability to consistently provide quality...
Empatica
April 15, 2021
www.prnewswire.com:443
/PRNewswire/ -- EmbracePlus de Empatica ha recibido la marca CE europea como dispositivo médico de clase lla, por su capacidad para proporcionar constantemente...
Conor Hale
April 6, 2021
FierceBiotech
Pear Therapeutics is building out its app-based digital treatment platform into something a little more tangible with the addition of wearable sensors and activity trackers.
Conor Hale
March 10, 2021
FierceBiotech
The makers of a wearable device designed to automatically detect epileptic seizures and call for help have their eyes set on COVID-19--with a newly obtained approval in Europe for a device that detects respiratory infections before symptoms appear.
Empatica
March 9, 2021
www.prnewswire.com:443
/PRNewswire/ -- Empatica, le fabriquant de biomarqueurs numériques et de dispositifs médicaux, a obtenu la certification CE pour son système Aura qui permet la...
Empatica
March 9, 2021
www.prnewswire.com:443
/PRNewswire/ -- Das Unternehmen für digitale Biomarker und medizinische Geräte Empatica erhält die CE-Zertifizierung für sein Aura-System zur frühzeitigen...
Empatica
March 9, 2021
www.prnewswire.com:443
/PRNewswire/ -- La compañía de biomarcadores digitales y dispositivos médicos Empatica recibe la certificación CE para su sistema Aura para detectar y alertar...
Empatica
November 6, 2020
www.prnewswire.com:443
/PRNewswire/ -- Empatica has been selected by the U.S. Army Medical Research and Development Command (USAMRDC) to deploy a wearable and algorithm that enable...
Empatica
November 6, 2020
www.prnewswire.com:443
/PRNewswire/ -- Empatica wurde vom U.S. Army Medical Research and Development Command (USAMRDC) mit der Bereitstellung eines Wearables und eines Algorithmus...
Empatica
November 6, 2020
www.prnewswire.com:443
/PRNewswire/ -- Empatica ha sido seleccionada por el U.S. Army Medical Research and Development Command (USAMRDC) para desplegar un dispositivo y un algoritmo...
Empatica
November 6, 2020
www.prnewswire.com:443
/PRNewswire/ -- Empatica a été sélectionné par le Commandement de la recherche et du développement médical de l'armée américaine (USAMRDC) pour déployer un...

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.